Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Janux Therapeutics, Inc. | 74,098 | reported | 11 Jun 2025 | tx 8+55,065 |
| Orthofix Medical Inc. | 25,185 | reported | 10 Mar 2026 | tx 6+62,204 |
| ARS Pharmaceuticals, Inc. | 18,000 | reported | 10 Jun 2022 | tx 4+80,928 |
| Otonomy, Inc. | 3,400 | reported | 28 Nov 2022 | tx 13+168,412−63,154 |
| Synthorx, Inc. | 0 | reported | 23 Jan 2020 | tx 3+15,335−77,747 |
| NUVASIVE INC | 0 | reported | 01 Sept 2023 | tx 22+33,662−33,662 |
| CONNECTURE INC | 0 | reported | 25 Apr 2018 | tx 6+136,898−136,898 |
| SENORX INC | 0 | reported | 06 Jul 2010 | tx 16+55,707−55,707 |
| DJ ORTHOPEDICS INC | 0 | reported | 20 Nov 2007 | tx 194+108,000−482,428 |
| AMEDISYS INC | 0 | reported | 14 Aug 2025 | tx 9+9,818−9,818 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Mar 2026 | PURCHASE | Orthofix Medical Inc. | 2,500 | 12.48 USD | first after silence |
| 10 Mar 2026 | PURCHASE | Orthofix Medical Inc. | 2,400 | 12.45 USD | |
| 10 Mar 2026 | PURCHASE | Orthofix Medical Inc. | 100 | 12.44 USD | |
| 14 Aug 2025 | OTHER | AMEDISYS INC | 9,818 | — | |
| 18 Jun 2025 | GRANT_AWARD | Orthofix Medical Inc. | 18,841 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 3,750 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 11,667 | 0.00 USD | deriv |
| 03 May 2025 | GRANT_AWARD | AMEDISYS INC | 1,690 | 0.00 USD | |
| 11 Mar 2025 | GRANT_AWARD | Orthofix Medical Inc. | 3,093 | 0.00 USD | |
| 11 Mar 2025 | GRANT_AWARD | Orthofix Medical Inc. | 35,270 | 0.00 USD | deriv |
| 05 Nov 2024 | OTHER | Janux Therapeutics, Inc. | 2,305 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 8,350 | 0.00 USD | deriv |
| 03 May 2024 | GRANT_AWARD | AMEDISYS INC | 1,678 | 0.00 USD | |
| 29 Feb 2024 | OTHER | Janux Therapeutics, Inc. | 1,493 | 0.00 USD | |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 2,000 | — | |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 2,130 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 3,788 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 2,702 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 4,001 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 2,501 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 2,822 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 4,816 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 3,230 | 0.00 USD | deriv |
| 01 Sept 2023 | OTHER | NUVASIVE INC | 2,577 | 0.00 USD | deriv |
5 purchases reported after at least 12 months of silence — most recent on 09 Mar 2026.